Skip to content

To Study The Effect Of Homoeopathic Medicines On Breast Lumps

To Assess The Effect Of Individualized Homoeopathic Medicine In 50 Millesimal Scale On Changes In Image Of Ultrasonography In Patients Of Fibroadenosis Of Breast An Open Label Prospective Clinical Study - No

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/11/098209
Enrollment
35
Registered
2025-11-28
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N602- Fibroadenosis of breast

Interventions

Intervention1: Individualized Homoeopathic Medicine In 50 Millesimal Scale: Indicated Individualized Homoeopathic Medicine Will be Prescribed To Patients Suffering From Fibroadenosis Of Breast .Dose A

Sponsors

National Institute Of Homoeopathy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Participants Who Are Having Sign And Symptomes Of Fibroadenosis Of Breast. Participants Diagnosed With Fibroadenosis Of Breast Meet Diagnostic Criteria Like Ultrasonography Diagnostic Tools. Participants Diagnosed With Fibroadenosis Of Breast With Birads Score Less Than 3 Should Be Included. Participants Of Any Religion Affiliation And Socio Economic Conditions. Participants Aged Between 20 To 50 Years. Participants Who Are Ready To Provide Written Informed Consent For Participation In The Study.

Exclusion criteria

Exclusion criteria: Participants Currently Receiving Homoeopathic Treatment For Any Chronic Condition . Participants With Uncontrolled Unevaluated Or Complicated Diabetes Mellitus Hypertension And Other Comorbidities Should Be Excluded. Participants Diagnosed With Fibroadenosis Of Breast With Birads Score More Than 3 Should Be Excluded. Participants Currently Undergoing Treatment For Fibroadenosis Breast With Other Therapies. Pregnant And Breastfeeding Women Should Be Excluded. Participants Who Are Taking Oral Contraceptive Pills And Hormonal Treatments Should Be Excluded. Participants On Substance Abuse Should Be Excluded.

Design outcomes

Primary

MeasureTime frame
BIRADS ScoreTimepoint: Baseline And 6 Months.

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Ramkrishna Ghosh

National Institute Of Homoeopathy

drrkghosh@yahoo.com8777656585

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026